Collagenase Versus Placebo in the Treatment of Peyronie’s Disease: A Double-blind Study
Authors:
- 1 January 1993
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 149 (1) , 56-58
Abstract
We investigated 49 men with Peyronie's disease in a prospectively randomized placebo controlled double-blind study, comparing the effects on plaque size and penile deformity of intralesional purified clostridial collagenase and saline placebo. For the group as a whole, treatment out-performed placebo (p < 0.007). When patients were analyzed with respect to disease severity, those with lesser deformity responded more favorably to treatment. The absolute angular change in patients responding to treatment was small. No significant side effects were noted within a 3-month followup.Keywords
This publication has 5 references indexed in Scilit:
- The Natural History of Peyronie’s DiseaseJournal of Urology, 1990
- Controlled vacuum chamber for standardized photographic documentation of penile erectile deformityUrology, 1990
- Humoral Immune Responses in Peyronie’s Disease Patients Receiving Clostridial Collagenase TherapyJournal of Urology, 1986
- The Use of Collagenase in the Treatment of Peyronie’s DiseaseJournal of Urology, 1985
- Classification of Congenital and Acquired Penile DeviationUrologia Internationalis, 1983